Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

IMPORTANCE: COVID-19 is a life-threatening illness for many patients. Prior studies have established hematologic cancers as a risk factor associated with particularly poor outcomes from COVID-19. To our knowledge, no studies have established a beneficial role for anti–COVID-19 interventions in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Michael A., Henderson, Jeffrey P., Shah, Pankil K., Rubinstein, Samuel M., Joyner, Michael J., Choueiri, Toni K., Flora, Daniel B., Griffiths, Elizabeth A., Gulati, Anthony P., Hwang, Clara, Koshkin, Vadim S., Papadopoulos, Esperanza B., Robilotti, Elizabeth V., Su, Christopher T., Wulff-Burchfield, Elizabeth M., Xie, Zhuoer, Yu, Peter Paul, Mishra, Sanjay, Senefeld, Jonathon W., Shah, Dimpy P., Warner, Jeremy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377563/
https://www.ncbi.nlm.nih.gov/pubmed/34137799
http://dx.doi.org/10.1001/jamaoncol.2021.1799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377563/
https://www.ncbi.nlm.nih.gov/pubmed/34137799
http://dx.doi.org/10.1001/jamaoncol.2021.1799

Ejemplares similares